Beam Global (NASDAQ:BEEM – Get Free Report) had its price objective lowered by equities research analysts at HC Wainwright from $30.00 to $8.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 100.00% from the […]

Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) had its price objective cut by investment analysts at HC Wainwright from $7.00 to $6.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 47.06% from the stock’s previous […]